Susquehanna International Group
VOR icon

Susquehanna International Group’s Vor Biopharma VOR Stock Holding History

Susquehanna International Group’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.15M Buy
232,608
+217,789
+1,470% +$3.07M ﹤0.01% 4589
2025
Q4 		$194K Buy
+14,819
New +$276K ﹤0.01% 10906
2025
Q2 		– Sell
-19,215
Closed -$170K – 13801
2025
Q1 		$276K Buy
19,215
+13,464
+234% +$323K ﹤0.01% 10242
2024
Q4 		$128K Buy
+5,751
New +$95.3K ﹤0.01% 11141
2024
Q3 		– Sell
-12,358
Closed -$247K – 13130
2024
Q2 		$247K Buy
12,358
+11,029
+830% +$357K ﹤0.01% 9882
2024
Q1 		$63K Sell
1,329
-1,850
-58% -$81.2K ﹤0.01% 11463
2023
Q4 		$143K Buy
3,179
+537
+20% +$22.2K ﹤0.01% 11016
2023
Q3 		$112K Sell
2,642
-833
-24% -$45.2K ﹤0.01% 10821
2023
Q2 		$215K Sell
3,475
-13,073
-79% -$1.19M ﹤0.01% 10139
2023
Q1 		$1.78M Buy
16,548
+14,153
+591% +$1.57M ﹤0.01% 5398
2022
Q4 		$319K Buy
+2,395
New +$237K ﹤0.01% 8946
2022
Q3 		– Sell
-2,654
Closed -$264K – 14202
2022
Q2 		$264K Buy
+2,654
New +$272K ﹤0.01% 9907
2022
Q1 		– Sell
-618
Closed -$144K – 14064
2021
Q4 		$144K Buy
+618
New +$178K ﹤0.01% 11840

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's VOR Position: Q1 2026 in Review

Susquehanna International Group increased its Vor Biopharma (VOR) stake by 1,470% in Q1 2026, buying an estimated $3.07M and bringing the position to 232,608 shares worth $4.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4589.

Susquehanna International Group first reported a position in VOR in Q4 2021 and has held it in 13 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Susquehanna International Group held 232,608 shares of Vor Biopharma worth $4.15M as of Q1 2026.
  • Susquehanna International Group bought 217,789 Vor Biopharma shares in Q1 2026, an estimated $3.07M.
  • Vor Biopharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4589 holding.
  • Susquehanna International Group first reported a position in Vor Biopharma in Q4 2021 and has held it in 13 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.